SEC Form 4 · accession 0001236031-18-000017
CEL SCI CORP · CVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eyal Talor
Officer — Chief Scientific Officer
Period of report
May 1, 2018
Accepted (ET)
May 3, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000725363
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1,F2 | $2.45 | May 1, 2018 | A | 13,934 | A | — | Apr 30, 2028 | Common Stock | 13,934 | 159,497 | D |
| OptionsF2 | $2.45 | May 1, 2018 | A | 180,000 | A | — | Apr 30, 2028 | Common Stock | 180,000 | 339,497 | D |
Explanation of responses
- F1The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred.
- F2The stock options vest in three (3) equal annual installments commencing one year after the grant date.